| Previous Close | 35.45 |
| Open | 35.93 |
| Bid | 36.00 x 300 |
| Ask | 36.07 x 100 |
| Day's Range | 35.81 - 36.21 |
| 52 Week Range | 29.83 - 36.21 |
| Volume | 25,679,577 |
| Avg. Volume | 17,372,446 |
| Market Cap | 214.05B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.33 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.62%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- The Wall Street Journal•2 minutes ago
[$$] Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies
Pfizer filed suit against Johnson & Johnson alleging it has thwarted competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering Pfizer’s lower-priced ...
- Market Realist•3 hours ago
Pfizer’s Revenues in Review: PFE’s Quarterly Performance
Pfizer (PFE) reported revenues of ~$12.9 billion in 2Q17, which was ~2% lower than its revenues of ~$13.2 billion in 2Q16.
- Business Insider•4 hours ago
Pfizer is taking its fight with J&J over a blockbuster drug to court
Two of the world's largest drugmakers are heading to court over a blockbuster arthritis treatment...
